Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 17, 2023

Primary Completion Date

November 6, 2023

Study Completion Date

January 7, 2024

Conditions

Stroke, Acute Ischemic

Interventions

PROCEDURE

Intracalvaria bone marrow injection

Intracalvaria bone marrow injection Y-3 (dose was given at 32 ug/kg), continuous medication for 3 days

OTHER

Conventional treatment

standard treatment and management according to related guidelines

Trial Locations (1)

Beijing Tiantan Hospital, Beijing

All Listed Sponsors

lead

Beijing Tiantan Hospital

OTHER